V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180003561 | 180002091 | null | null | null | null | 2019-09-17 | Mitotane 5.5 - 10g | null | null | SELPERCATINIB | 100243533 |
| 180003673 | 180002102 | null | null | null | null | 2017-05-08 | Irinotecan + Temozolomide | null | null | CARBOPLATIN + PACLITAXEL | 100183213 |
| 180003737 | 180002109 | 0 | null | null | null | 2018-05-15 | NB HRNBL-1 COJEC Ind COURSE B | null | null | LENVATINIB | 101188547 |
| 180003839 | 180002118 | null | null | null | 2020-01-09 | 2020-01-25 | NB BEACON Dinutuximab and Temozolomide | null | null | RITUXIMAB | 100094221 |
| 180003929 | 180002125 | null | null | null | 2017-12-25 | 2018-08-28 | VANDETANIB | null | null | NB HRNBL-1 CH14.18/CHO(TRIAL) +IL-2 | 101532194 |
| 180004003 | 180002131 | null | null | null | 2020-01-19 | 2020-02-01 | NB HRNBL-1 Isotretinoin | null | null | FLUOROURACIL + OXALIPLATIN | 101639241 |
| 180004084 | 180002136 | null | null | null | null | 2021-03-14 | NB BEACON Temozolomide Topotecan | null | null | LENVATINIB | 100248608 |
| 180004181 | 180002138 | null | null | null | null | 2021-12-16 | FEC 100 | null | null | NB HRNBL-1 ISOTRETINOIN | 100233700 |
| 180004280 | 180002144 | null | null | null | 2020-11-13 | 2021-08-14 | NB HRNBL-1 COJEC Ind COURSE B | null | null | CABOZANTINIB | 101861534 |
| 180004334 | 180002149 | null | null | null | null | 2017-11-25 | SACITUZUMAB GOVITECAN | null | null | TRABECTEDIN | 101155291 |
| 180004407 | 180002152 | null | null | null | null | 2016-06-28 | null | null | null | CABOZANTINIB | 101520126 |
| 180004419 | 180002153 | null | null | null | 2016-05-07 | 2016-05-07 | Cisplatin + Etoposide (3 day) | null | null | CARBOPLATIN + PACLITAXEL | 101263786 |
| 180004426 | 180002154 | null | null | null | 2016-04-14 | 2016-04-14 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | LENVATINIB | 101443813 |
| 180004507 | 180002158 | null | null | null | null | 2021-06-30 | PERTUZUMAB + TRASTUZUMAB | null | null | NB HRNBL-1 CH14.18/CHO(TRIAL) +IL-2 | 100337265 |
| 180004536 | 180002160 | null | null | null | null | 2019-10-18 | Vinblastine | null | null | CABOZANTINIB | 101376188 |
| 180004541 | 180002161 | null | null | null | null | 2019-12-09 | CNS GCT II Germinoma - Ifos Etop | null | null | LENVATINIB | 100403978 |
| 180004626 | 180002168 | null | null | null | 2016-04-28 | 2016-05-05 | R GCVP | null | null | MITOTANE | 101486943 |
| 180004659 | 180002169 | null | null | null | 2022-03-03 | 2022-05-04 | Carboplatin + Paclitaxel (3 weekly) | null | null | NB HRNBL-1 ISOTRETINOIN | 100777204 |
| 180004820 | 180002178 | null | null | null | null | 2020-10-10 | ETOPOSIDE | null | null | PEMBROLIZUMAB | 100943504 |
| 180004826 | 180002179 | null | null | null | null | 2017-07-17 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | null | null | CAPECITABINE + OXALIPLATIN | 100564879 |
| 180004847 | 180002181 | null | null | null | null | 2019-12-12 | PACLITAXEL | null | null | CARBOPLATIN + PEMETREXED | 101273900 |
| 180004880 | 180002183 | null | null | null | null | 2021-01-26 | LENVATINIB | null | null | NB LOW/INTERMED RISK GUIDELINES CADO | 100312563 |
| 180004943 | 180002188 | null | null | null | null | 2018-06-24 | WT SIOP 2002 01 post op Carbo, Etop | null | null | NOT MATCHED | 100113751 |
| 180004987 | 180002190 | null | null | null | null | 2018-12-31 | NB HRNBL-1 COJEC Ind COURSE C | null | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 100689094 |
| 180005044 | 180002193 | null | null | null | 2021-05-17 | 2021-05-25 | CARBOPLATIN + PACLITAXEL | null | null | NB HRNBL-1 ISOTRETINOIN | 100055181 |
| 180005156 | 180002200 | null | null | null | null | 2019-08-07 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | ABEMACICLIB + FULVESTRANT | 101307661 |
| 180005172 | 180002201 | null | null | null | 2016-06-07 | 2017-03-14 | GEMCITABINE | null | null | TRETINOIN | 100098960 |
| 180005180 | 180002202 | null | null | null | null | 2019-08-13 | Docetaxel 75mg/m2 (21 day) | null | null | SORAFENIB | 101125274 |
| 180005183 | 180002203 | null | null | null | 2018-07-19 | 2018-07-19 | CABOZANTINIB | null | null | TEMOZOLOMIDE | 101373887 |
| 180005202 | 180002206 | null | null | null | null | 2018-08-27 | Folfirinox | null | null | PEMBROLIZUMAB | 100961839 |
| 180005222 | 180002208 | null | null | null | 2018-09-09 | 2018-09-30 | IBRUTINIB | null | null | PACLITAXEL | 101168368 |
| 180005234 | 180002210 | null | null | null | null | 2018-03-21 | CYCLO + DOXORUBICIN + VINCRISTINE | null | null | CARBOPLATIN + PACLITAXEL | 101213183 |
| 180005302 | 180002220 | null | null | null | null | 2019-07-05 | CABOZANTINIB | null | null | CAPECITABINE + GEMCITABINE | 100842329 |
| 180005339 | 180002223 | null | null | null | null | 2019-03-03 | CABOZANTINIB | null | null | CISPLATIN + ETOPOSIDE | 100815541 |
| 180005368 | 180002224 | null | null | null | null | 2019-01-11 | NB HRNBL-1 COJEC Ind COURSE B | null | null | LENVATINIB | 101124008 |
| 180005369 | 180002225 | null | null | null | null | 2016-12-22 | IPILIMUMAB + NIVOLUMAB | null | null | CNS MEDBL ST RISK WEEKLY VINCRISTINE | 101475349 |
| 180005473 | 180002229 | null | null | null | null | 2019-03-20 | EDP | null | null | NB HRNBL-1 ISOTRETINOIN | 100748983 |
| 180005501 | 180002231 | null | null | null | 2018-05-04 | 2018-05-11 | NB HRNBL-1 COJEC Ind COURSE C | null | null | NB HRNBL-1 ISOTRETINOIN | 100695740 |
| 180005507 | 180002233 | null | null | null | 2019-02-12 | 2019-02-12 | CETUXIMAB + IRINOTECAN + MDG | null | null | SORAFENIB | 100344343 |
| 180005526 | 180002234 | null | null | null | null | 2016-11-10 | null | null | null | CAPECITABINE + TEMOZOLOMIDE | 101692772 |
| 180005582 | 180002236 | null | null | null | null | 2017-03-07 | FCarboSt | null | null | FLUOROURACIL + IRINOTECAN | 101123944 |
| 180005611 | 180002240 | null | null | null | null | 2016-06-04 | Ipilimumab | null | null | NB HRNBL-1 ISOTRETINOIN | 101416236 |
| 180005621 | 180002242 | null | null | null | null | 2019-01-09 | NB HRNBL-1 Isotretinoin | null | null | DABRAFENIB + TRAMETINIB | 100363941 |
| 180005624 | 180002243 | null | null | null | 2022-02-01 | 2022-02-08 | GEMCITABINE + NAB PACLITAXEL | null | null | CARBOPLATIN | 101466426 |
| 180005907 | 180002262 | null | null | null | null | 2019-01-21 | NB HRNBL-1 TVD | null | null | LENVATINIB | 101101259 |
| 180005953 | 180002264 | null | null | null | null | 2020-01-29 | Carboplatin + Pemetrexed | null | null | LENVATINIB | 100484746 |
| 180006008 | 180002268 | null | null | null | 2017-01-15 | 2017-02-05 | null | null | null | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 101712023 |
| 180006018 | 180002269 | null | null | null | null | 2018-08-07 | Cyclophosphamide High Dose | null | null | CARBOPLATIN + VINORELBINE | 101384741 |
| 180006051 | 180002271 | null | null | null | null | 2017-01-24 | Lomustine | null | null | SELPERCATINIB | 100981618 |
| 180006085 | 180002273 | null | null | null | null | 2018-02-21 | Cisplatin | null | null | LENVATINIB | 100078225 |